Zurich / Hamburg, 7th January 2026
Selectchemie AG today announced that it has signed an agreement to sell its Nutrition business unit to TER Chemicals, a family-owned international distributor of specialty chemicals and food additives headquartered in Hamburg. The agreement was concluded in Zurich in December 2025. The transaction represents an important step in Selectchemie’s strategic development and further strengthens the company’s clear focus on the pharmaceutical business – in particular on active pharmaceutical ingredi-ents (APIs), excipients, finished dosage forms (FDFs) and dossiers, as well as specialized services for the pharmaceutical industry.
The nutrition business unit, which has operated in the market under the name Selectnutrition, has been an established partner in the Food & Nutrition sector for decades. It has built a broad product and supplier portfolio as well as a well-established network in the Swiss market. The further development of the business will be pursued under the umbrella of TER. With this divestment, Selectchemie will align its portfolio even more consistently with the pharmaceutical environment – a field in which the company has demonstrated strong expertise, an extensive partner network and significant growth potential for more than five decades.
As privately owned companies, Selectchemie and TER share core values such as long-term thinking, reliability, responsibility, and a strong focus on customers and employees. This cultural alignment made TER an ideal partner for the future of the Nutrition business unit.
As part of the agreement, TER Chemicals will take over all Nutrition employees and ensure a smooth integration into its existing Swiss entity, TER Schweiz AG. Both companies are working closely togeth-er to ensure an orderly and transparent transition.
“With the acquisition of Selectnutrition, we are strengthening our European position in the Food & Nutrition sector and creating the foundation for further growth in Switzerland and beyond with innovative solutions. We are delighted to welcome all employees of Selectnutrition to the TER Group and to shape the future together with them,” explains Andreas Früh, CEO of the TER Chemicals Group.
The completion of the transaction is expected as of 1 April 2026, subject to customary regulatory ap-provals. A transition phase has been agreed on to ensure the smooth continuation of all ongoing busi-ness activities and partnerships.
„This step follows a clear strategic direction” said Oliver Kühn, CEO of Selectchemie AG. „Our future clearly lies in the pharmaceutical business. This is where our strengths are, and where we expect further growth. With TER, we have found an owner who not only complements the Nutrition business unit from a professional perspective but also shares our values. This gives us great confidence that employees, customers and suppliers are in very good hands, and that the business will be developed sustainably and in a spirit of trust going forward.”
Media contact Selectchemie AG: Julia Norris [media@selectchemie.com]
Download the full press release here
